Abstract: The present invention is directed to a compound of Formula I: and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, or combination thereof, a composition comprising the thiosemicarbazone, a method of administration thereof, and use thereof to treat a cancer.
Type:
Application
Filed:
January 11, 2008
Publication date:
July 17, 2008
Applicant:
6441513 CANADA INC.
Inventors:
Wayne R. Danter, Martyn Brown, Franck LePifre